In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for obsessive-compulsive disorder than cannabinoids.

Like priests or your own lawyer, doctors are in that category of people where, technically, you should feel safe to share ...

A new study suggests that a moderate dose of psilocybin can effectively reduce symptoms of obsessive-compulsive disorder for ...

Big Health Inc, along with paid academic investigators, reports higher remission rates and lower anxiety symptom scores with ...

Learn which pets are most commonly hoarded and how unchecked breeding and mental health issues drive animal overcrowding.

This year, psychological scientists tackled profound and varied questions to help us better understand ourselves and the ...

The FDA has cleared LumosityRx to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type ADHD.

This umbrella review synthesised five meta-analyses to estimate the reported prevalence of orthorexia nervosa and examine its ...

Are rising ADHD diagnoses a cultural trend, a misunderstanding, or evidence of a real neurodevelopmental difference? This ...

An abbreviated version of the Brain Care Score predicts risk for dementia, stroke, and late-life depression based on lifestyle factors alone.

The findings of this study could eventually improve how mental health conditions are diagnosed and treated, especially for ...